News

  • 10 October 2019

    Parexel signs data technology deal with Datavant

    Biopharmaceutical services provider Parexel has entered a multi-year collaboration with healthcare data services firm Datavant to link real-world data across clinical trials.

  • 10 October 2019

    Debiopharm begins enrolment in CATRIPCA trial

    Debiopharm has started enrolling patients in its CATRIPCA Phase I clinical trial evaluating Debio 1143 in combination with Merck’s Keytruda for the treatment of cancer.

Close
Close
Close

Go Top